Stacy R. Lindborg’s interest in statistics came from a strength in mathematics, a biproduct of having an engineer as a father who thought studying math in the summer was cool. After earning her PhD, she took a job working for Eli Lilly & Company. As she began working on data, she learned one of the greatest strengths as a statistician lies in the depth of knowledge of the data. Since then, Stacy has worked on drugs targeting serious neurological and neurodegenerative diseases in addition to cancer, cardiovascular disease, diabetes, immunology, and pain. She has also served in numerous leadership roles, including head of R&D strategy, general product management leadership, and her current role as chief development officer.
Amstat News
The Membership Magazine of the American Statistical Association